The efficacy of inhibiting tumour necrosis factor and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons
New treatments that inhibit the cytokines tumour necrosis factor alpha (TNFalpha) and interleukin 1 (IL-1) in the treatment of rheumatoid arthritis have proven clinical effect against placebo and methotrexate (MTX) in several clinical trials in early and late-stage disease and different severity gro...
שמור ב:
Main Authors: | , , |
---|---|
פורמט: | Revisão |
שפה: | אנגלית |
יצא לאור: |
2007
|
גישה מקוונת: | https://doi.org/10.1093/rheumatology/kem072 https://academic.oup.com/rheumatology/article-pdf/46/7/1140/9449311/kem072.pdf |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|